Banca Mediolanum Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Banca MediolanumDer Gewinn des Unternehmens wird voraussichtlich um 3.9% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 13.8% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich sinken um 2.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 20.6% betragen.

Wichtige Informationen

-3.9%

Wachstumsrate der Gewinne

-2.2%

EPS-Wachstumsrate

Diversified Financial Gewinnwachstum	26.6%
Wachstumsrate der Einnahmen	13.8%
Zukünftige Eigenkapitalrendite	20.6%
Analystenabdeckung	Good
Zuletzt aktualisiert	18 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Banca Mediolanum S.p.A. (BIT:BMED) Just Released Its Interim Earnings: Here's What Analysts Think

Aug 04

Recent updates

Banca Mediolanum (BIT:BMED) Will Pay A Dividend Of €0.37

Nov 15

If EPS Growth Is Important To You, Banca Mediolanum (BIT:BMED) Presents An Opportunity

Sep 09

Banca Mediolanum S.p.A. (BIT:BMED) Just Released Its Interim Earnings: Here's What Analysts Think

Aug 04

I Ran A Stock Scan For Earnings Growth And Banca Mediolanum (BIT:BMED) Passed With Ease

Apr 08

Here's Why We Think Banca Mediolanum (BIT:BMED) Is Well Worth Watching

Dec 21

New Forecasts: Here's What Analysts Think The Future Holds For Banca Mediolanum S.p.A. (BIT:BMED)

Feb 15

How Many Banca Mediolanum S.p.A. (BIT:BMED) Shares Did Insiders Buy, In The Last Year?

Jan 31

If You Had Bought Banca Mediolanum's (BIT:BMED) Shares A Year Ago You Would Be Down 21%

Dec 28

Here's Why I Think Banca Mediolanum (BIT:BMED) Is An Interesting Stock

Nov 23

Gewinn- und Umsatzwachstumsprognosen

BIT:BMED - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	3,162	876	835	N/A	2
12/31/2025	3,094	881	848	N/A	3
12/31/2024	3,064	999	872	N/A	2
9/30/2024	2,091	924	N/A	N/A	N/A
6/30/2024	2,066	908	581	631	N/A
3/31/2024	1,984	864	N/A	N/A	N/A
12/31/2023	1,870	822	-1,806	-1,754	N/A
9/30/2023	1,712	702	N/A	N/A	N/A
6/30/2023	1,587	629	132	200	N/A
3/31/2023	1,468	571	N/A	N/A	N/A
12/31/2022	1,377	507	2,239	2,298	N/A
9/30/2022	1,585	714	N/A	N/A	N/A
6/30/2022	1,547	685	1,034	1,093	N/A
3/31/2022	1,585	694	N/A	N/A	N/A
12/31/2021	1,599	713	848	909	N/A
9/30/2021	1,425	560	N/A	N/A	N/A
6/30/2021	1,408	553	81	119	N/A
3/31/2021	1,310	496	N/A	N/A	N/A
12/31/2020	1,215	434	-18	24	N/A
9/30/2020	1,457	531	N/A	N/A	N/A
6/30/2020	1,445	545	162	192	N/A
3/31/2020	1,470	566	N/A	N/A	N/A
12/31/2019	1,469	565	328	363	N/A
9/30/2019	1,038	268	N/A	N/A	N/A
6/30/2019	1,012	252	257	305	N/A
3/31/2019	1,005	268	N/A	N/A	N/A
12/31/2018	987	256	312	357	N/A
9/30/2018	1,031	373	181	248	N/A
6/30/2018	1,006	359	N/A	278	N/A
3/31/2018	944	355	N/A	N/A	N/A
12/31/2017	970	380	N/A	275	N/A
9/30/2017	938	368	N/A	N/A	N/A
6/30/2017	983	420	N/A	-789	N/A
3/31/2017	1,007	405	N/A	N/A	N/A
12/31/2016	985	394	N/A	-849	N/A
9/30/2016	1,068	432	N/A	N/A	N/A
6/30/2016	1,014	382	N/A	155	N/A
3/31/2016	1,009	374	N/A	N/A	N/A
12/31/2015	1,103	439	N/A	-7,651	N/A
12/31/2013	868	188	N/A	-454	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BMEDFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-3.9% pro Jahr).

Ertrag vs. Markt: BMEDFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-3.9% pro Jahr).

Hohe Wachstumserträge: BMEDFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: BMEDDie Einnahmen des Unternehmens (13.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Italian (4% pro Jahr).

Hohe Wachstumseinnahmen: BMEDDie Einnahmen des Unternehmens (13.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: BMEDDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (20.6%)

Banca Mediolanum Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Banca Mediolanum S.p.A. (BIT:BMED) Just Released Its Interim Earnings: Here's What Analysts Think

Price target increased by 7.6% to €10.68

Analysts update estimates

Recent updates

Banca Mediolanum (BIT:BMED) Will Pay A Dividend Of €0.37

Dividend of €0.37 announced

If EPS Growth Is Important To You, Banca Mediolanum (BIT:BMED) Presents An Opportunity

Banca Mediolanum S.p.A. (BIT:BMED) Just Released Its Interim Earnings: Here's What Analysts Think

Second quarter 2024 earnings released: EPS: €0.31 (vs €0.25 in 2Q 2023)

Banca Mediolanum S.p.A. (BIT:BMED) commences an Equity Buyback for 8,000,000 shares, representing 1.08% for €66 million, under the authorization approved on April 18, 2024.

New major risk - Revenue and earnings growth

First quarter 2024 earnings: Revenues exceed analyst expectations

Is Now The Time To Put Banca Mediolanum (BIT:BMED) On Your Watchlist?

Upcoming dividend of €0.42 per share

Banca Mediolanum (BIT:BMED) Will Pay A Larger Dividend Than Last Year At €0.42

Final dividend of €0.42 announced

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: EPS: €0.28 (vs €0.18 in 3Q 2022)

Now 21% undervalued

Second quarter 2023 earnings released: EPS: €0.25 (vs €0.17 in 2Q 2022)

Now 20% undervalued after recent price drop

Upcoming dividend of €0.26 per share at 6.0% yield

Now 21% undervalued

Price target increased by 7.6% to €10.68

Full year 2022 earnings released: EPS: €0.71 (vs €0.97 in FY 2021)

Should You Be Adding Banca Mediolanum (BIT:BMED) To Your Watchlist Today?

Banca Mediolanum S.p.A. to Report Q1, 2023 Results on May 10, 2023

Upcoming dividend of €0.24 per share

Third quarter 2022 earnings released

Banca Mediolanum (BIT:BMED) Has Affirmed Its Dividend Of €0.24

Here's Why We Think Banca Mediolanum (BIT:BMED) Is Well Worth Watching

Banca Mediolanum S.p.A. to Report Q3, 2022 Results on Nov 09, 2022

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues miss analyst expectations

Upcoming dividend of €0.35 per share

I Ran A Stock Scan For Earnings Growth And Banca Mediolanum (BIT:BMED) Passed With Ease

CEO & Director recently bought €167k worth of stock

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Now 22% undervalued after recent price drop

Banca Mediolanum S.P.A. Proposes Balanced Dividend Distribution for the Year 2021

Banca Mediolanum S.p.A. to Report Fiscal Year 2021 Results on Feb 10, 2022

Now 22% undervalued after recent price drop

Here's Why We Think Banca Mediolanum (BIT:BMED) Is Well Worth Watching

Third quarter 2021 earnings released

Upcoming dividend of €0.75 per share

Second quarter 2021 earnings released: EPS €0.18 (vs €0.11 in 2Q 2020)

Upcoming dividend of €0.027 per share

New 90-day high: €7.75

New Forecasts: Here's What Analysts Think The Future Holds For Banca Mediolanum S.p.A. (BIT:BMED)

Full year 2020 earnings released

Banca Mediolanum S.p.A. to Report Q3, 2021 Results on Nov 10, 2021

Investor sentiment improved over the past week

How Many Banca Mediolanum S.p.A. (BIT:BMED) Shares Did Insiders Buy, In The Last Year?

Analysts update estimates

If You Had Bought Banca Mediolanum's (BIT:BMED) Shares A Year Ago You Would Be Down 21%

Here's Why I Think Banca Mediolanum (BIT:BMED) Is An Interesting Stock

Third quarter 2020 earnings released: EPS €0.14

New 90-day low: €6.05

New 90-day low: €6.15

First half earnings released

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken